organophosphonates has been researched along with prasugrel hydrochloride in 1 studies
Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (prasugrel hydrochloride) | Trials (prasugrel hydrochloride) | Recent Studies (post-2010) (prasugrel hydrochloride) |
---|---|---|---|---|---|
9,968 | 880 | 3,596 | 1,803 | 396 | 1,458 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Baumann, M; Dingemanse, J; Dobrow, M; Juif, PE; Riederer, MA; Schilling, U; Ufer, M | 1 |
1 trial(s) available for organophosphonates and prasugrel hydrochloride
Article | Year |
---|---|
Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor.
Topics: Adult; Aged; Clopidogrel; Cross-Over Studies; Double-Blind Method; Drug Interactions; Drug Substitution; Female; Humans; Male; Middle Aged; Organophosphonates; Platelet Aggregation; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Pyrimidines; Ticagrelor; Time Factors; Treatment Outcome; Young Adult | 2021 |